TABLE 1

Overview of Mouse Conditions and Performed Scans

Test no.Mouse strainCellsPETCTBLIWeight (g)
nSiteCell lineAmountDayTracerLesionsMice+DayLesionsMice+DayLesionsMice+MeanSD
1nu/nu3SCN2a1.5E+06818F-FDG1181127.20.5
1318F-FDG11131129.00.5
2018F-FDG33203330.80.8
2nu/nu4SCC60.5E+061218F-FDG44124426.51.1
1718F-FDG44174428.01.6
3nu/nu3ICA375M1.5E+062118F-FDG11210027.81.9
3018F-FDG32302225.84.2
4SCID5IVA375M-Fluc0.7E+064518F-FDG6445645*531.51.1
5nu/nu3ICB16F00.5E+061718F-FDG3176319.33.5
6nu/nu6ICA375M-3F1.5E+06000
30026.61.4
60027.51.6
91128.31.3
152229.41.6
186428.60.7
228429.01.3
2611529.02.2
2818F-FHBG74284327.92.7
2913527.43.4
3018F-FDG633043
3518F-FHBG105355427.42.4
  • * Because of limited resolution of BLI, number of lesions could not be determined.

  • Poor 18F-FDG uptake in B16F0 metastasis precluded assessment of metastases.

  • Only the 4 mice positive for 18F-FHBG were scanned.

  • SC = subcutaneous; IC = intracardiac; IV = intravenous.